Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 03, 2025 06:08 ET | Source: Research and Markets

The Insulin Pen Market in Japan, 2025-2033 - Rising Demand for Easy-to-Use Insulin Pens Amid Japan's Aging Population Drive Revenues to a Projected $515 Million by 2033

Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "Japan Insulin Pen Market Growth Outlook 2025-2033" has been added to ResearchAndMarkets.com's offering.The Japan Insulin Pen Market is forecasted to...
October 21, 2025 09:30 ET | Source: Research and Markets

United States Rapid Acting Insulin Research Report 2025: A $3.4 Billion Market by 2033 Featuring Adocia, Biocon, Eli Lilly, Gan & Lee, Geropharm, MannKind, Merck, Novo Nordisk, Sanofi, Wockhardt

Dublin, Oct. 21, 2025 (GLOBE NEWSWIRE) -- The "United States Rapid Acting Insulin Market Report by Product, Indication, Distribution Channel, States and Company Analysis, 2025-2033" report has been...
October 16, 2025 06:20 ET | Source: Research and Markets

U.S. Semaglutide Market Trends and Investment Strategies 2025-2033: Retail Pharmacies Play Key Role in Distribution Amid Growing Demand

Dublin, Oct. 16, 2025 (GLOBE NEWSWIRE) -- The "United States Semaglutide Market Report by Product, Application, Distribution Channel, States and Company Analysis, 2025-2033" has been added to ...
September 25, 2025 02:30 ET | Source: Arecor Therapeutics PLC

Arecor announces Co-development Agreement with US Insulin Pump Device Company for AT278 & Sale of Royalty Rights and Technology Access Fees for AT220 and AT292

Arecor Therapeutics announces Co-development Agreement for AT278 with Sequel Med Tech and Sale of Royalty and Technology Access Fees for up to $11m
September 01, 2025 11:13 ET | Source: Research and Markets

Insulin Delivery Device Company Evaluation Report 2025 | Embecta, Novo Nordisk, and Ypsomed Lead with Innovative Injection and Digital Management Solutions

Dublin, Sept. 01, 2025 (GLOBE NEWSWIRE) -- The "Insulin Delivery Device - Company Evaluation Report, 2025" report has been added to ResearchAndMarkets.com's offering.The Insulin Delivery Devices...
August 20, 2025 21:11 ET | Source: Shenzhen Hengsheng Hospital

Latest breakthrough in Type 1 diabetes treatment: Chinese medical team enables 24 patients to discontinue insulin use

SHENZHEN, China, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Recently, Professor An Chiying and her medical team at Shenzhen Hengsheng Hospital, China, announced a groundbreaking achievement: since June 2024,...
August 20, 2025 04:35 ET | Source: Research and Markets

Medicaments Containing Insulin - International Trade in Q2 2025: Top Markets' Performance by Major Competitors

Dublin, Aug. 20, 2025 (GLOBE NEWSWIRE) -- The "Medicaments Containing Insulin - International Trade in Q2 2025: Top Markets' Performance by Major Competitors" has been added to ...
August 08, 2025 06:11 ET | Source: Research and Markets

Thyroid Eye Disease Pipeline Market Research 2025 | Emerging Therapies Pipeline Features Advanced Monoclonal Antibodies and Novel Inhibitors in Late-Stage Clinical Development

Dublin, Aug. 08, 2025 (GLOBE NEWSWIRE) -- The "Thyroid Eye Disease - Pipeline Insight, 2025" has been added to ResearchAndMarkets.com's offering. The report offers an extensive examination of...
July 23, 2025 10:28 ET | Source: Research and Markets

Insulin Pumps Market Outlook Report 2025, with Leading Player Profiles for Medtronic, Insulet, Tandem Diabetes Care, and More

Dublin, July 23, 2025 (GLOBE NEWSWIRE) -- The "Insulin Pumps Market - Focused Insights 2021-2030" report has been added to ResearchAndMarkets.com's offering.The Insulin Pumps Market was valued at...
July 15, 2025 15:25 ET | Source: Biocon Biologics Ltd

Biocon Biologics Expands Diabetes Portfolio with FDA Approval of Kirsty™, the First and Only Interchangeable Rapid-Acting Insulin Aspart in the United States

BRIDGEWATER, N.J., United States and BENGALURU, Karnataka, India, July 15, 2025 (GLOBE NEWSWIRE) -- Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon...